Meta: Strong Fundamentals, Buy On Dips — Neutral

META   Seeking Alpha — February 17, 2025

Meta Platforms, formerly Facebook, has seen a significant stock rise but is currently priced near perfectly, considering its growth, advancements in AI, and ad spending headwinds. Despite a strong Q4 2024, Meta's Q1 2025 revenue guidance and high total expenses raise some concerns, but I believe the management is being conservative in the provided guidance. Deceleration in global ad spending growth and reduced political ad spending could impact Meta's revenue growth, despite strong fundamentals in its Family of Apps.

image for news Meta: Strong Fundamentals, Buy On Dips

Impinj Stock Plunges 21% in a Month: Hold Tight or Time to Let Go? — Negative

PI   Zacks Investment Research — February 17, 2025

Considering the ongoing geopolitical risks, excess market capacity and bearish signal from a key technical indicator, it is prudent to sell PI stock for now.

image for news Impinj Stock Plunges 21% in a Month: Hold Tight or Time to Let Go?

Cameco: Valuation Is Neither Lofty Nor Harsh — Neutral

CCJ   Seeking Alpha — February 17, 2025

Cameco's valuation is justified by strong uranium demand and nuclear energy revival, but it must meet growth expectations to sustain current price multiples. Cameco's operations span uranium production, fuel services, and a 49% stake in Westinghouse, contributing significantly to its revenue and growth prospects. Future growth hinges on increased uranium production, favorable pricing, and maintaining a strong balance sheet, despite potential risks from market fluctuations and legal disputes.

image for news Cameco: Valuation Is Neither Lofty Nor Harsh

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=130046&wire=1 or contact Joseph E. Levi, Esq.

image for news April 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against - ICLR

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=130051&wire=1 or contact Joseph E.

image for news Shareholders that Lost Money on FTAI Aviation Ltd. (FTAI) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=130047&wire=1 or contact Joseph E. Levi, Esq.

image for news Investors Who Lost Money on Regeneron Pharmaceuticals, Inc. (REGN) Should Contact Levi & Korsinsky About Pending Class Action - REGN

Garmin to Report Q4 Earnings: What's in Store for the Stock? — Positive

GRMN   Zacks Investment Research — February 17, 2025

GRMN's fourth-quarter 2024 results are likely to benefit from growth in its fitness, marine, aviation, auto OEM and outdoor end markets.

image for news Garmin to Report Q4 Earnings: What's in Store for the Stock?

Meta Platforms: Why You'll Regret Not Buying The Stock Today — Neutral

META   Seeking Alpha — February 17, 2025

Meta Platforms' stock surged from $479 to $725 due to strong advertising performance and substantial operating profit growth, making it a compelling investment. META reported better-than-expected 4Q24 results, with $8.02 EPS and a 43% YoY increase in operating profit, driven by high demand for online ads. Meta Platforms is projected to grow operating profits beyond $100 billion in 2025, supported by robust advertising prices and significant AI investments.

image for news Meta Platforms: Why You'll Regret Not Buying The Stock Today

Vornado Realty Trust Q4 Earnings: If You Want Office, Buy The Best — Positive

VNO   Seeking Alpha — February 17, 2025

The office market continues to struggle post-pandemic, with high vacancy rates and distressed assets, but top operators like VNO are showing resilience. VNO's strong Q4 2024 earnings and significant leasing activity in NYC indicate a potential market recovery, with shares appreciating over 70% in the past year. VNO's strategic share repurchases and operational efficiencies have contributed to its success, despite the broader market challenges and high vacancy rates in Manhattan.

image for news Vornado Realty Trust Q4 Earnings: If You Want Office, Buy The Best

Is Warren Buffett Preparing For a Market Crash? This Move Says Yes — Neutral

BRK-A  BRK-B   24/7 Wall Street — February 17, 2025

For six decades, Warren Buffett has dominated the investing world.

image for news Is Warren Buffett Preparing For a Market Crash? This Move Says Yes

Compass to Report Q4 Earnings: What's in Store for the Stock? — Neutral

COMP   Zacks Investment Research — February 17, 2025

COMP's fourth-quarter performance is expected to have benefited from recent launches of tools in its technology platform amid seasonal pressure seen each year.

image for news Compass to Report Q4 Earnings: What's in Store for the Stock?

Ken Griffin 's hedge fund Citadel has placed a £305 million ($390 million) short bet against GSK PLC GSK, marking the largest wager against the UK pharma giant in over a decade, reported the Financial Times.

image for news Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

image for news Shareholder Rights Advocates at Levi & Korsinsky Investigate Harmonic Inc. (HLIT) Regarding Possible Securities Fraud Violations

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=130043&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance, Inc. Lawsuit - WBA

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=130044&wire=1 or contact Joseph E. Levi, Esq.

image for news GSK plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=130040&wire=1 or contact Joseph E. Levi, Esq.

image for news Grocery Outlet Holding Corp. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights - GO

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=130042&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Shareholders of Pacira BioSciences, Inc.(PCRX) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=130048&wire=1 or contact Joseph E. Levi, Esq.

image for news Lost Money on Merck & Co., Inc. (MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=130049&wire=1 or contact Joseph E. Levi, Esq.

image for news Lost Money on Integral Ad Science Holding Corp. (IAS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=130038&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Shareholders of Novo Nordisk A/S (NVO) of a Class Action Lawsuit and an Upcoming Deadline